MM #274: Stocks That Benefit From Trump, Nvidia’s Top Risk, Ozempic $2B Lawsuits, & September Market Strategy
This week’s Market Mondays is packed with high-level investing questions and timely market insights. We break down which five companies could thrive under a Trump administration, discuss whether Nvidia has a revenue concentration problem, and share advice for investors earning $50K–$100K per year on how to balance…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like Market Mondays →
Nvidia’s Record Setting Run… And Trump’s Powell Pressure Ramps Up 7/15/25
The Five Stocks Driving the Market in 2023
The Exact Investing Plan for 2026: Even If You're Starting From $0
Markets Love Certainty
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.